KUCHARCHUK ANDREW ALBERT 4
4 · CERO THERAPEUTICS HOLDINGS, INC. · Filed Jun 2, 2025
Insider Transaction Report
Form 4
KUCHARCHUK ANDREW ALBERT
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-05-30+152,500→ 152,500 totalExercise: $0.45Exp: 2035-05-29→ Common Stock (152,500 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest in equal monthly installments through June 4, 2027.